Annual SGA
$4.37 M
-$84.00 K-1.89%
December 1, 2023
Summary
- As of February 12, 2025, PHIO annual SGA is $4.37 million, with the most recent change of -$84.00 thousand (-1.89%) on December 1, 2023.
- During the last 3 years, PHIO annual SGA has fallen by -$711.00 thousand (-14.00%).
- PHIO annual SGA is now -28.96% below its all-time high of $6.15 million, reached on December 31, 2011.
Performance
PHIO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$946.00 K
-$102.00 K-9.73%
September 1, 2024
Summary
- As of February 12, 2025, PHIO quarterly SGA is $946.00 thousand, with the most recent change of -$102.00 thousand (-9.73%) on September 1, 2024.
- Over the past year, PHIO quarterly SGA has dropped by -$22.00 thousand (-2.27%).
- PHIO quarterly SGA is now -69.67% below its all-time high of $3.12 million, reached on March 31, 2011.
Performance
PHIO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$568.50 M
-$7.42 M-1.32%
September 1, 2024
Summary
- As of February 12, 2025, PHIO TTM SGA is -$568.50 million, with the most recent change of -$7.42 million (-1.32%) on September 1, 2024.
- Over the past year, PHIO TTM SGA has dropped by -$573.22 million (-12154.75%).
- PHIO TTM SGA is now -13192.07% below its all-time high of -$4.28 million.
Performance
PHIO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PHIO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.9% | -2.3% | -10000.0% |
| 3 y3 years | -14.0% | -2.3% | -10000.0% |
| 5 y5 years | +37.5% | -2.3% | -10000.0% |
PHIO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -5.6% | at low | -35.6% | +23.5% | -27.2% | at low |
| 5 y | 5-year | -14.0% | at low | -52.7% | +23.5% | -55.7% | at low |
| alltime | all time | -29.0% | +66.6% | -69.7% | +354.8% | <-9999.0% | at low |
Phio Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $946.00 K(-9.7%) | $3.82 M(-0.6%) |
| Jun 2024 | - | $1.05 M(-1.2%) | $3.84 M(-2.9%) |
| Mar 2024 | - | $1.06 M(+38.5%) | $3.96 M(-9.3%) |
| Dec 2023 | $4.37 M(-1.9%) | $766.00 K(-20.9%) | $4.37 M(-7.4%) |
| Sep 2023 | - | $968.00 K(-16.8%) | $4.72 M(-2.0%) |
| Jun 2023 | - | $1.16 M(-20.7%) | $4.81 M(-1.1%) |
| Mar 2023 | - | $1.47 M(+31.5%) | $4.86 M(+9.3%) |
| Dec 2022 | $4.45 M(-3.8%) | $1.12 M(+5.0%) | $4.45 M(-2.4%) |
| Sep 2022 | - | $1.06 M(-12.7%) | $4.56 M(-0.1%) |
| Jun 2022 | - | $1.22 M(+15.5%) | $4.56 M(+2.1%) |
| Mar 2022 | - | $1.05 M(-14.0%) | $4.47 M(-3.4%) |
| Dec 2021 | $4.63 M(-8.9%) | $1.23 M(+14.9%) | $4.63 M(-14.3%) |
| Sep 2021 | - | $1.07 M(-5.2%) | $5.40 M(+0.3%) |
| Jun 2021 | - | $1.13 M(-6.9%) | $5.38 M(+4.6%) |
| Mar 2021 | - | $1.21 M(-39.5%) | $5.15 M(+1.4%) |
| Dec 2020 | $5.08 M(+7.8%) | $2.00 M(+90.4%) | $5.08 M(+7.5%) |
| Sep 2020 | - | $1.05 M(+18.0%) | $4.72 M(-0.4%) |
| Jun 2020 | - | $890.00 K(-21.8%) | $4.75 M(-0.5%) |
| Mar 2020 | - | $1.14 M(-30.9%) | $4.77 M(+1.3%) |
| Dec 2019 | $4.71 M(+48.2%) | $1.65 M(+53.7%) | $4.71 M(+22.2%) |
| Sep 2019 | - | $1.07 M(+17.3%) | $3.85 M(+10.3%) |
| Jun 2019 | - | $913.00 K(-15.3%) | $3.49 M(+4.1%) |
| Mar 2019 | - | $1.08 M(+36.5%) | $3.35 M(+5.6%) |
| Dec 2018 | $3.18 M(-20.8%) | $790.00 K(+11.1%) | $3.18 M(-0.4%) |
| Sep 2018 | - | $711.00 K(-8.1%) | $3.19 M(-7.9%) |
| Jun 2018 | - | $774.00 K(-14.1%) | $3.46 M(-8.6%) |
| Mar 2018 | - | $901.00 K(+12.3%) | $3.79 M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $4.01 M(+10.8%) | $802.00 K(-18.7%) | $4.01 M(-5.4%) |
| Sep 2017 | - | $986.00 K(-10.4%) | $4.24 M(+5.8%) |
| Jun 2017 | - | $1.10 M(-2.0%) | $4.01 M(+5.7%) |
| Mar 2017 | - | $1.12 M(+8.8%) | $3.79 M(+4.8%) |
| Dec 2016 | $3.62 M(+8.2%) | $1.03 M(+37.2%) | $3.62 M(+29.5%) |
| Sep 2016 | - | $752.00 K(-15.0%) | $2.79 M(-7.6%) |
| Jun 2016 | - | $885.00 K(-6.8%) | $3.02 M(+2.8%) |
| Mar 2016 | - | $950.00 K(+356.7%) | $2.94 M(+2.7%) |
| Dec 2015 | $3.35 M(+4.0%) | $208.00 K(-78.8%) | $2.87 M(-16.1%) |
| Sep 2015 | - | $981.00 K(+22.0%) | $3.42 M(+6.7%) |
| Jun 2015 | - | $804.00 K(-7.9%) | $3.20 M(-1.4%) |
| Mar 2015 | - | $873.00 K(+15.2%) | $3.25 M(+0.9%) |
| Dec 2014 | $3.22 M(-13.0%) | $758.00 K(-1.0%) | $3.22 M(-9.8%) |
| Sep 2014 | - | $766.00 K(-9.9%) | $3.57 M(-4.5%) |
| Jun 2014 | - | $850.00 K(+0.8%) | $3.74 M(-3.3%) |
| Mar 2014 | - | $843.00 K(-24.0%) | $3.86 M(+4.5%) |
| Dec 2013 | $3.70 M(+41.1%) | $1.11 M(+18.7%) | $3.70 M(+15.4%) |
| Sep 2013 | - | $934.00 K(-4.4%) | $3.20 M(+14.1%) |
| Jun 2013 | - | $977.00 K(+44.5%) | $2.81 M(+10.3%) |
| Mar 2013 | - | $676.00 K(+9.9%) | $2.55 M(-7.7%) |
| Dec 2012 | $2.62 M(-57.4%) | $615.00 K(+14.1%) | $2.76 M(-10.5%) |
| Sep 2012 | - | $539.00 K(-24.7%) | $3.08 M(-14.0%) |
| Jun 2012 | - | $716.00 K(-19.4%) | $3.58 M(-8.4%) |
| Mar 2012 | - | $888.00 K(-5.5%) | $3.92 M(-36.3%) |
| Dec 2011 | $6.15 M | $940.00 K(-9.7%) | $6.15 M(+18.1%) |
| Sep 2011 | - | $1.04 M(-0.5%) | $5.21 M(+25.0%) |
| Jun 2011 | - | $1.05 M(-66.5%) | $4.17 M(+33.5%) |
| Mar 2011 | - | $3.12 M | $3.12 M |
FAQ
- What is Phio Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals annual SGA year-on-year change?
- What is Phio Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals quarterly SGA year-on-year change?
- What is Phio Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals TTM SGA year-on-year change?
What is Phio Pharmaceuticals annual SGA?
The current annual SGA of PHIO is $4.37 M
What is the all time high annual SGA for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high annual SGA is $6.15 M
What is Phio Pharmaceuticals annual SGA year-on-year change?
Over the past year, PHIO annual SGA has changed by -$84.00 K (-1.89%)
What is Phio Pharmaceuticals quarterly SGA?
The current quarterly SGA of PHIO is $946.00 K
What is the all time high quarterly SGA for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high quarterly SGA is $3.12 M
What is Phio Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, PHIO quarterly SGA has changed by -$22.00 K (-2.27%)
What is Phio Pharmaceuticals TTM SGA?
The current TTM SGA of PHIO is -$568.50 M
What is the all time high TTM SGA for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high TTM SGA is -$4.28 M
What is Phio Pharmaceuticals TTM SGA year-on-year change?
Over the past year, PHIO TTM SGA has changed by -$573.22 M (-12154.75%)